WS #10157
USTR initiated a Section 301 investigation against Germany over pharmaceutical pricing, potentially impacting German pharma companies.
US Initiates Section 301 Investigation Against Germany
USTR initiated a Section 301 investigation against Germany over pharmaceutical pricing, potentially impacting German pharma companies.